Syneos Health Stock Gross Profit
SYNHDelisted Stock | USD 42.31 0.07 0.17% |
Syneos Health fundamentals help investors to digest information that contributes to Syneos Health's financial success or failures. It also enables traders to predict the movement of Syneos Stock. The fundamental analysis module provides a way to measure Syneos Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Syneos Health stock.
Syneos |
Syneos Health Company Gross Profit Analysis
Syneos Health's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Syneos Health Gross Profit | 1.25 B |
Most of Syneos Health's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syneos Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Syneos Health reported 1.25 B of gross profit. This is 44.09% lower than that of the Life Sciences Tools & Services sector and 40.38% higher than that of the Health Care industry. The gross profit for all United States stocks is 95.42% higher than that of the company.
Syneos Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Syneos Health's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics of similar companies.Syneos Health is currently under evaluation in gross profit category among its peers.
Syneos Fundamentals
Return On Equity | 0.0209 | |||
Return On Asset | 0.0263 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.06 % | |||
Current Valuation | 7.23 B | |||
Shares Outstanding | 103.72 M | |||
Shares Owned By Insiders | 0.48 % | |||
Shares Owned By Institutions | 94.74 % | |||
Number Of Shares Shorted | 6.76 M | |||
Price To Earning | 18.05 X | |||
Price To Book | 1.07 X | |||
Price To Sales | 0.66 X | |||
Revenue | 5.39 B | |||
Gross Profit | 1.25 B | |||
EBITDA | 699.99 M | |||
Net Income | 266.5 M | |||
Cash And Equivalents | 124.2 M | |||
Cash Per Share | 1.21 X | |||
Total Debt | 2.9 B | |||
Debt To Equity | 0.93 % | |||
Current Ratio | 1.10 X | |||
Book Value Per Share | 33.69 X | |||
Cash Flow From Operations | 426.98 M | |||
Short Ratio | 5.59 X | |||
Earnings Per Share | 0.70 X | |||
Price To Earnings To Growth | 1.28 X | |||
Target Price | 42.5 | |||
Number Of Employees | 28.77 K | |||
Beta | 1.58 | |||
Market Capitalization | 4.43 B | |||
Total Asset | 8.2 B | |||
Retained Earnings | 167.69 M | |||
Working Capital | 219.25 M | |||
Current Asset | 1.09 B | |||
Current Liabilities | 1.07 B | |||
Z Score | 1.92 | |||
Net Asset | 8.2 B |
About Syneos Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |